| Literature DB >> 6142067 |
B I Korelitz, D H Present, P H Rubin, S E Fochios.
Abstract
Desensitization to sulfasalazine was successful in 40/47 (85%) patients with IBD who previously had hypersensitivity reactions. The desensitization with sulfasalazine was well-tolerated with no serious complications in short- or long-term follow-up. The course of IBD was subsequently favorable in 35/40 (87%) for extended periods including 17/17 (100%) with ulcerative colitis. Desensitization should be attempted in patients who have had typical hypersensitivity reactions to sulfasalazine.Entities:
Mesh：
Substances：
Year: 1984 PMID： 6142067
Source DB: PubMed Journal: J Clin Gastroenterol ISSN： 0192-0790 Impact factor: 3.062